A study of dementia in adults with down’s syndrome using 99Tcm-hmpao spet

Nuclear Medicine Communications

Volumn 18, Issue 7, 1997, Pages 662-667

  Jones, A M ^a   Kennedy, N ^a   Hanson, J ^a   Fenton, G W ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADOLESCENT; ADULT; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; DEMENTIA; DETERIORATION; DOWN SYNDROME; FEMALE; HUMAN; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGE FACTORS; BRAIN; DEMENTIA; DOWN SYNDROME; FEMALE; HUMANS; MALE; MENTAL RETARDATION; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030812287     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199707000-00011     Document Type: Article

References (31)

1. Struwe F. Histopathologische Untersuchungen Über Enste-hung und Wessen der senilen Plaques. A Gesamte Neurol Psychiatr 1929; 122: 291.
2. Jervis GA. Early senile dementia in mogoloid idiocy. Am f Psychiat 1948; 105: 102-106.
3. Olson MI, Shaw CM. Presenile dementia and Alzheimer’s disease in mongolism. Brain 1969; 92: 147-156.
4. Wisniewski KE, Wisniewski HM, Wen GY. Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome. Ann Neurol 1985; 17: 278-282.
5. Oliver C, Holland AJ. Down’s syndrome and Alzheimer’s disease: A review. Psych Med 1986; 16: 307-322.
6. Zigman WB, Schupf N, Lubin RA et al. Premature regression of adults with Down’s syndrome. Am J Mental Defic 1987; 92: 161-168.
7. Cork LC. Neuropathology of Down’s syndrome and Alzheimer’s disease. Am J Med Genet 1990; 7 (suppl.): 282-286.
8. Evenhuis HM. The natural history of dementia in Down’s syndrome. Arch Neurol 1990; 47: 263-267.
9. Malamud GM. The neuropathology of mental retardation. In Philips J, ed. Prevention and treatment of mental retardation. New York: Basic Books, 1972: 24-32.
10. Hopper AH, Williams RS. Relationship between plaques, tangle and dementia in Down’s syndrome. Neurology 1980; 30: 639-644.
11. Brun A, Gustafson L. Distribution of cerebral degeneration in Alzheimer’s disease: A clinico-pathological study. Arch Psychiat Nenvnkr 1976; 233: 15-33.
12. Wisniewski HM, Rabe A. Discrepancy between Alzheimer type neuropathology and dementia in persons with Down’s syndrome. Ann NY Acad Sei 1986; 466: 247-260.
13. Lai F, Williams RS. A prospective study of Alzheimer disease in Down’s syndrome. Arch Neurol 1980; 46: 849-853.
14. Lund J. Psychiatric aspects of Down’s syndrome. Acta Psy-chiat Scand 1988; 78: 369-374.
15. Franceschi M, Comola M, Piattoni F, Gualandri W, Canal N. Prevalence of dementia in adult patients with trisomy 21. Am J Med Genet 1990; 7 (suppl.): 306-308.
16. Johanson A, Gustafson L, Bum A, Risberg J, Rosen I, Tide-man EA. Longitudinal study of dementia of Alzheimer type in Down’s syndrome. Dementia 1991; 2: 159-168.
17. Gemmell H, Sharp O, Besson J et al. Differential diagnosis in dementia using the cerebral blood flow agent 99-m-tc-HMPAO: A SPECT study. J Comput Assist Tomogr 1987; 11: 398-402.
18. Neary D, Snowden JS, Shields RA et al. SPECT using TcHMPAO in the investigation of dementia. J Neurol Neu-orsurg Psychiat 1987; 50: 1101-1109.
19. Geaney DP, Soper N, Shepstone BJ, Cowen PJ. Central cholingergic stimulation in regional cerebral blood flow in Alzheimer disease, lancet 1990; 335: 1483-1487.
20. Miller BL, Mena I, Daly J et al. Temporal-parietal perfusion with single-photon emission computerised tomography in conditions other than Alzheimer’s disease. Dementia 1990; 1: 41-45.
21. Holman BL, Johnson KA, Gerada B, Carvallo PA, Satlin A. The scintigraphic appearance of Alzheimer’s disease: A prospective study with TcHMPAO SPECT. J Nucl Med 1992; 33: 181-185.
22. Schapiro MB, Haxby JV, Grady CL. The nature of mental retardation and dementia in Down’s syndrome with PET, CT and neuropsychology. Neurobiol Aging 1992; 13: 723-734.
23. Bums A, Philpot MP, Costa DC, Ell PJ, Levy R. An investigation of Alzheimer’s disease with single photon emission tomography. J Neurol Neurosurg Psychiat 1989; 52: 248-253.
24. Montaldi D, Brooks DN, McColl JH et al. Measurements of regional cerebral blood flow and cognitive performance in Alzheimer’s disease. J Neurol Neurosurg Psychiat 1990; 53: 33-38.
25. O’Brien JT, Eagger S, Syed GMS, Sahakian B, Levy, R. A study of regional cerebral flow and cognitive performance in Alzheimer’s disease. J Neurol Neurosurg Psychiat 1992; 55: 1182.
26. Launes J, Sulkara R, Erikjuntii T et al. 99Tcm HMPAO SPECT in suspected dementia. Nucl Med 1991; 12: 757-765.
27. Deb S, de Silva PN, Gemmell HG, Besson JAO, Smith FW, Ebmeier KP. Alzheimer’s disease in adults with Down’s syndrome: The relationship between regional cerebral blood flow equivalents and dementia. Acta Psychiat Scand 1992; 86: 340-345.
28. Newroth A, Newroth S. Coping with Alzheimer’s disease-a growing concern. Toronto: National Institute on Mental Retardation of the Canadian Association for the Mentally Retarded, 1980.
29. McMurdo ME, Grant DJ, Kennedy NSJ, Gilchrist J, Findlay DJ, McLennan JM. ‘Hie value of HMPAO SPECT scanning in the diagnosis of early Alzheimer’s disease in patients attending a memory clinic. Nucl Med Commuti 1994; 15: 405-409.
30. Kao CH, Wang PY, Wang SJ, Chou KT, Hsu CY, Lin NY, Wao SQ, Yeh SH. Regional cerebral blood flow of Alzheimer’s disease-like pattern in young patients with Down’s syndrome detected by 99Tcm-HMPAO brain SPECT. Nucl Med Commuti 1993; 14: 47-51.
31. Sloan EP, Fenton GW, Kennedy NSJ, McLennan JM. Electroencephalography and single photon emission computerised tomography in dementia: A comparative study. Psych Med 1995; 25: 631-638.